Position in BCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$147,200
New position
Shares Held
14,720
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#225
of 316 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $37,173,300 across 16 Drug Manufacturers - Specialty & Generic names. BCRX ranks #13 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
331,500 | $11,231,220 | |
| 2 | PRGO |
PERRIGO Co plc
|
874,359 | $9,084,590 | |
| 3 | ZTS |
Zoetis Inc.
|
69,200 | $4,972,712 | |
| 4 | VTRS |
Viatris Inc
|
203,200 | $3,226,816 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
125,000 | $3,076,250 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
24,000 | $2,662,560 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
23,000 | $1,069,730 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,860 | $568,675 |
All Filings in BCRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $147,200 | 14,720 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||